Cascade and CRISPR
Cascade and CRISPR help bacteria remember how to fight viral infection
Living organisms are under constant attack by viruses and have evolved an effective set of weapons to fight them. Bacteria and archaea take several approaches. They have several hardwired systems that fight the most common attackers. For instance, restriction enzymes stand ready to cut up the DNA of invading viruses. They also have a more adaptive system, akin to our own immune system, that can be tuned to protect against the viruses that are present at any given time. This system, termed CRISPR-Cas, stores information on current threats and provides the weapons to destroy them.
Archive of Infection
Bacteria use CRISPR sequences, stored in their genome, to identify attacking viruses. The name stands for "clustered regularly interspaced short palindromic repeats," which refers to the unusual pattern of sequences found in CRISPR DNA. They are composed of many small pieces of viral DNA harvested from viruses that attacked in the past, separated by a distinctive repeated sequence used to create the archive. Remarkably, new sequences are added at the beginning of this collection, so we can read the CRISPR sequence to get a history of viruses that have attacked the bacterial population in the past.
A system of Cas proteins (short for "CRISPR-associated proteins") use this stored information to fight the viruses if they try to infect the bacteria again. The center of this system is the large complex Cascade. It carries an RNA transcript of the CRISPR sequence and searches through the cell for matching viral DNA from an infection. If it finds viral DNA, it unwinds it and mobilizes nucleases to cut it up. The structure shown here includes the Cascade surveillance complex composed of 6 different types of proteins (in different shades of blue) along with the RNA transcript (red) (PDB entries 4tvx
Cascade works with a team of proteins to build the CRISPR archive and use it to protect against viruses. First, recruiting proteins like Cas1 and Cas2 (PDB entry 4p6i
) are needed to chop up viruses during an infection and save appropriately-sized bits in the CRISPR. These pieces are then displayed by Cascade to search for later infections by the virus. If the virus is found, Cas3 (PDB entry 4qqw
) is the executioner, taking the infecting viral DNA found by Cascade and destroying it.
Cas9 and Cures
Different bacteria and archaea have evolved a number of variations on this general theme. The Cascade complex, termed Type I, displays CRISPR RNA and recruits the executioner Cas3 to chop up the viral DNA. Type III complexes, on the other hand, have the DNA-cutting enzyme as part of the complex. Type II CRISPR systems, such as Cas9 (PDB entries 4un3
) have a surveillance protein and executioner all wrapped up in a single protein chain. The complex shown here includes the CRISPR RNA (red) along with a piece of an attacking viral DNA (yellow). This molecule has recently been used in an experimental approach to curing latent HIV infection. An engineered virus was used to insert Cas9 and an anti-HIV CRISPR into HIV-infected cells, which then chopped up the integrated viral DNA.
Exploring the Structure
Cascade (PDB entry 4qyz)
PDB entry 4qyz captures Cascade in action. The structure includes the strand of CRISPR RNA (red) and a short piece of the viral DNA (yellow) after it has been unwound and recognized. The structure revealed a surprising but very logical structure for the RNA and DNA. The RNA is stretched open in a long spiral groove in Cascade, and the DNA binds side-by-side, instead of in the classical double helix. To explore this amazing structure in more detail, click on the image for an interactive JSmol.
Topics for Further Discussion
- When reading articles about CRISPR sequences, watch out for some of the terminology, because it can be confusing. For instance, the term "spacer" is often used to refer to the short pieces of viral DNA that are stored in the CRISPR, and "repeat" is used to refer to the short repeated sequences separating each piece of viral DNA.
- Many of these large CRISPR/Cas complexes have been characterized by electron microscopy. For instance, to see the structure of a type III complex (which is different from type I Cascade and type II Cas9) take a look at the EMDataBank.
- J. van der Oost, E. R. Westra, R. N. Jackson & B. Wiedenheft (2014) Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nature Reviews Microbiology 12, 479-492.
- H. Ebina, N. Misawa, Y. Kanemura & Y. Koyanagi (2013) Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus. Scientific Reports 3, 2510.
- 4qqw: Y. Huo, K. H. Nam, F. Ding, H. Lee, L. Wu, Y. Xiao, M. D. Farchione, S. Zhou, K. Rajashankar, I. Kurinov, R. Zhang & A. Ke (2014) Structures of CRISPR Cas3 offer mechanistic insights into Cascade-activated DNA unwinding and degradation. Nature Structural & Molecular Biology 21, 771-777.
- 4un3: C. Anders, O. Niewoehner, A. Duerst & M. Jinek (2014) Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature 513, 569-573.
- 4tvx: R. N. Jackson, S. M. Golden, P. B. G. van Erg, J. Carter, E. R. Westra, S. J. J. Brouns, J. van der Oost, T. C. Terwilliger, R. J. Read & B. Wiedenheft. (2014) Crystal structure of the CRISPR RNA-guided surveillance complex from Escherichia coli. Science 345, 1473-1479.
- 4qyz: S. Mulepati, A. Heroux & S. Bailey (2014) Crystal structure of a CRISPR RNA-guided surveillance complex bound to a ssFNA target. Science 345, 1479-1484.
- 4p6i: J. K. Nunez, P. J. Kranzusch, J. Noeske, A. V. Wright, C. W. Davies & J. A. Doudna (2014) Cas1-Cas2 complex formation mediates spacer acquisition during CRISPR-Cas adaptive immunity. Nature Structural & Molecular Biology 21, 528-534.
January 2015, David Goodsell